High-Grade Glioma Clinical Trial
Official title:
A Phase 1b, Open-Label, Study of a Novel Targeted Radiotherapy in Children, Adolescents and Young Adults With Inoperable Relapsed or Refractory High-Grade Glioma
The purpose of this dose finding study is to evaluate the safety and efficacy of 2 different dose levels of CLR 131 in children, adolescents and young adults with relapsed or refractory high-grade glioma (HGG).
This study is designed to further evaluate the safety and tolerability of CLR 131 at the selected doses in children, adolescents and young adults with relapsed or refractory malignant high-grade glioma. It will also determine the therapeutic activity defined as progression free survival and overall survival, antitumor activity (treatment response) defined as the reduction in tumor volume and identify the recommended Phase 2/3 dose of CLR 131 in children, adolescents and young adults with relapsed or refractory HGG. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02305056 -
Study of Tumor Metabolism by Isotopic Tagging in Patients With High-grade Glioma (CARBONOMIC)
|
Phase 1 | |
| Not yet recruiting |
NCT06002711 -
Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gliomas: A Multi-Center Study
|
||
| Recruiting |
NCT04299191 -
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Terminated |
NCT00548938 -
Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
|
Phase 2 | |
| Completed |
NCT01644773 -
Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
|
Phase 1 | |
| Recruiting |
NCT02239952 -
HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)
|
N/A | |
| Completed |
NCT00565721 -
A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
|
Phase 2 | |
| Recruiting |
NCT05929456 -
Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)
|
Phase 1 | |
| Recruiting |
NCT04552756 -
Seizures During Radiotherapy for High-grade Gliomas
|
N/A | |
| Not yet recruiting |
NCT04482933 -
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
|
Phase 2 | |
| Terminated |
NCT04730349 -
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT05873946 -
Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
|
||
| Recruiting |
NCT02848794 -
Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06209567 -
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors
|
Early Phase 1 | |
| Not yet recruiting |
NCT06201351 -
Study of Adaptive Radiotherapy for High-grade Glioma Based on Interfraction MRI
|
||
| Recruiting |
NCT06118723 -
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
|
||
| Completed |
NCT00624728 -
Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)
|
Phase 1/Phase 2 | |
| Terminated |
NCT04851834 -
NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04908267 -
How the Precise Habitats Can Predict the IDH Mutation Status and Prognosis of the Patients With High-grade Gliomas
|
||
| Completed |
NCT03458312 -
Nurse-led Family and Network Consultations
|
N/A |